University of Queensland - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:Asia

Author(s):

Product Code:GDPH216970D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

September 2018

Total pages

45

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

University Of Queensland (UQ) is a research institute. The university manages personal, career, welfare and learning issues. It conducts research in the areas of physical sciences, biological sciences, technology, biomedical and clinical health sciences, engineering, chemical sciences and environmental sciences, among others. UQ provides educational courses in the areas of arts, architecture and information technology, business, economics and law, social and behavioural sciences. The university conducts research services through its research institutes. It also offers support to research higher degree students through a broad range of scholarships and research travel awards. UQ is headquartered in Brisbane, Queensland, Australia.

University of Queensland-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

University of Queensland, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Queensland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Queensland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Queensland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Queensland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Queensland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

University of Queensland, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Botanix Pharma Enters into Research Agreement with University of Queensland 10

Cyxone Enters into Agreement with University of Queensland 11

Agilent Technologies Enters Into Research Agreement With University of Queensland 12

LEO Pharma And University of Queensland Enter Into Research Agreement For Skin Cancer 13

Ascend Biopharma Enters into Agreement with University of Queensland 14

Johnson & Johnson Enters Into Co-Development Agreement With University of Queensland 15

Licensing Agreements 16

AngioStem Enters into Licensing Agreement with Queensland University 16

University of Queensland-Key Competitors 17

University of Queensland-Key Employees 18

University of Queensland-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 21

Government and Public Interest 21

Aug 30, 2018: New pathway in body's immune response uncovered 21

Aug 29, 2018: Potential medical breakthroughs receive national funding 22

Jul 30, 2018: Largest genetic study of type 2 diabetes offers hope of better treatment 23

Jul 25, 2018: Dutch Viagra trial on pregnant women stopped after 11 babies die 24

Jun 28, 2018: New treatment to reverse drug resistance in some cancers 25

Jan 24, 2018: USD 69 million boost for fight against rare cancers and rare diseases 26

Jan 05, 2018: Supercharged antibiotics could turn tide against superbugs 29

Nov 22, 2017: Researchers show stress suppresses response to cancer treatments 30

Nov 21, 2017: Cure Brain Cancer Foundation: 2017 Grant Recipients Announced 31

Nov 13, 2017: Research uncovers potential new approach for treating asthma 33

Oct 13, 2017: A new tactic in the fight against drug-resistant infections 34

Sep 06, 2017: Scientists link 153 new genetic variants to osteoporosis in largest ever study 35

Sep 01, 2017: Decoding cells a step forward in reproductive technology 36

Aug 01, 2017: Targeted treatment gives new hope on breast cancer 37

Jul 31, 2017: Study opens new drug therapy targets in a range of diseases 38

Product News 39

Apr 10, 2018: Technology holds personalised cancer vaccine breakthrough 39

Feb 20, 2018: NUST MISIS Scientists Create Hybrid Nanomaterials in Fight Against Cancer and Bacteria 40

Other Significant Developments 41

Aug 01, 2018: Stem cell research to tackle blindness and congenital heart disease in kids 41

Nov 09, 2017: Australia joins world-first Human Cell Atlas effort 43

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List of Figure

List of Figures

University of Queensland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Queensland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Queensland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Queensland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Queensland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Queensland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Queensland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Queensland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List of Table

List of Tables

University of Queensland, Pharmaceuticals & Healthcare, Key Facts, 2017 2

University of Queensland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Queensland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Queensland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Queensland, Deals By Therapy Area, 2012 to YTD 2018 8

University of Queensland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Botanix Pharma Enters into Research Agreement with University of Queensland 10

Cyxone Enters into Agreement with University of Queensland 11

Agilent Technologies Enters Into Research Agreement With University of Queensland 12

LEO Pharma And University of Queensland Enter Into Research Agreement For Skin Cancer 13

Ascend Biopharma Enters into Agreement with University of Queensland 14

Johnson & Johnson Enters Into Co-Development Agreement With University of Queensland 15

AngioStem Enters into Licensing Agreement with Queensland University 16

University of Queensland, Key Competitors 17

University of Queensland, Key Employees 18

University of Queensland, Subsidiaries 19

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022